AJANTA PHARMA LTD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?
AJANTA PHARMA LTD has sixty-two approved drugs.
There are three tentative approvals on AJANTA PHARMA LTD drugs.
Summary for AJANTA PHARMA LTD
US Patents: | 0 |
Tradenames: | 52 |
Ingredients: | 51 |
NDAs: | 62 |
Drug Master File Entries: | 2 |
Drugs and US Patents for AJANTA PHARMA LTD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ajanta Pharma Ltd | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 213897-001 | Oct 2, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ajanta Pharma Ltd | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | CAPSULE;ORAL | 209859-002 | Sep 27, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Ajanta Pharma Ltd | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 212624-003 | Sep 13, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ajanta Pharma Ltd | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 213621-001 | Dec 4, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.